Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jason L. Hornick, M.D.,Ph.D.

Co-Author

This page shows the publications co-authored by Jason Hornick and Paola Dal Cin.
Connection Strength

1.259
  1. Expression of ROS1 predicts ROS1 gene rearrangement in inflammatory myofibroblastic tumors. Mod Pathol. 2015 May; 28(5):732-9.
    View in: PubMed
    Score: 0.155
  2. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement. Am J Surg Pathol. 2012 Oct; 36(10):1444-51.
    View in: PubMed
    Score: 0.132
  3. Well-differentiated and dedifferentiated liposarcomas with prominent myxoid stroma: analysis of 56 cases. Histopathology. 2013 Jan; 62(2):287-93.
    View in: PubMed
    Score: 0.132
  4. MUC4 is a highly sensitive and specific marker for low-grade fibromyxoid sarcoma. Am J Surg Pathol. 2011 May; 35(5):733-41.
    View in: PubMed
    Score: 0.120
  5. Translocation (Y;12) in lipoma. Cancer Genet. 2011 Jan; 204(1):53-6.
    View in: PubMed
    Score: 0.117
  6. Hybrid myxoinflammatory fibroblastic sarcoma/hemosiderotic fibrolipomatous tumor: report of a case providing further evidence for a pathogenetic link. Am J Surg Pathol. 2010 Nov; 34(11):1723-7.
    View in: PubMed
    Score: 0.116
  7. Dedifferentiated liposarcoma with "homologous" lipoblastic (pleomorphic liposarcoma-like) differentiation: clinicopathologic and molecular analysis of a series suggesting revised diagnostic criteria. Am J Surg Pathol. 2010 Aug; 34(8):1122-31.
    View in: PubMed
    Score: 0.114
  8. Loss of INI1 expression is characteristic of both conventional and proximal-type epithelioid sarcoma. Am J Surg Pathol. 2009 Apr; 33(4):542-50.
    View in: PubMed
    Score: 0.104
  9. Characteristic nuclear membrane ALK reactivity in chronic myelomonocytic leukemia with RANBP2-ALK fusion. Am J Hematol. 2021 Jan 25.
    View in: PubMed
    Score: 0.059
  10. Intravenous leiomyomatosis: an unusual intermediate between benign and malignant uterine smooth muscle tumors. Mod Pathol. 2016 05; 29(5):500-10.
    View in: PubMed
    Score: 0.042
  11. Primary sclerosing epithelioid fibrosarcoma of bone: analysis of a series. Am J Surg Pathol. 2014 Nov; 38(11):1538-44.
    View in: PubMed
    Score: 0.038
  12. Dedifferentiated liposarcoma and pleomorphic liposarcoma: a comparative study of cytomorphology and MDM2/CDK4 expression on fine-needle aspiration. Cancer Cytopathol. 2014 Feb; 122(2):128-37.
    View in: PubMed
    Score: 0.036
  13. Cutaneous syncytial myoepithelioma: clinicopathologic characterization in a series of 38 cases. Am J Surg Pathol. 2013 May; 37(5):710-8.
    View in: PubMed
    Score: 0.034
  14. Angiomatoid fibrous histiocytoma a series of five cytologic cases with literature review and emphasis on diagnostic pitfalls. Diagn Cytopathol. 2012 Aug; 40 Suppl 2:E86-93.
    View in: PubMed
    Score: 0.031
  15. Crizotinib in ALK-rearranged inflammatory myofibroblastic tumor. N Engl J Med. 2010 Oct 28; 363(18):1727-33.
    View in: PubMed
    Score: 0.029
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.